在欧洲实现癌症护理的数字化转型:来自TRANSITION项目的实际建议
Dimitrios Protogiros1, Constantina Cloconi1, Theologia Tsitsi1
1Cyprus University of Technology, 30 Archbishop Kyprianos Street, Limassol 3036, Cyprus.
Journal of cancer policy
|April 10, 2025
概括
这项研究概述了癌症护理数字化转型的建议,强调劳动力培训和政策改进. 合作是成功实现欧洲医疗保健系统数字化转型的关键.
科学领域:
- 在瘤学瘤学.
- 数字健康数字健康
- 医疗保健管理的管理
背景情况:
- 癌症护理的数字化转型需要整合数字技术和数据分析.
- 瘤学的有效数字化转型取决于通过数字教育和培训充分准备劳动力.
研究的目的:
- 为瘤学领域的数字化转型制定推方案.
- 专注于加强医疗保健专业人员和卫生管理人员的数字培训.
主要方法:
- 采用了一种混合方法的方法.
- 包括快速的文献审查和专家小组调查.
- 是欧盟资助的 TRANSITION 项目的一部分.
主要成果:
- 确定了四个级别的建议:政策,教育,临床实践和研究.
- 这些建议是相互关联的,需要利益相关者在多个层面的合作.
结论:
- 提出的建议可以显著影响欧洲癌症护理的数字化转型.
- 强有力的政策领导和利益相关者合作对于快速数字化转型至关重要.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


